Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease

Jan O. Aasly, Carles Vilariño-Güell, Justus C. Dachsel, Philip J. Webber, Andrew B. West, Kristoffer Haugarvoll, Krisztina K. Johansen, Mathias Toft, John G. Nutt, Haydeh Payami, Jennifer M. Kachergus, Sarah J. Lincoln, Amela Felic, Christian Wider, Alexandra I. Soto-Ortolaza, Stephanie A. Cobb, Linda R. White, Owen A Ross, Matthew J. Farrer

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Genealogical investigation of a large Norwegian family (F04) with autosomal dominant parkinsonism has identified 18 affected family members over four generations. Genetic studies have revealed a novel pathogenic LRRK2 mutation c.4309 A>C (p.Asn1437His) that co-segregates with disease manifestation (LOD = 3.15, Θ = 0). Affected carriers have an early age at onset (48 ± 7.7 SD years) and are clinically asymmetric and levodopa responsive. The variant was absent in 623 Norwegian control subjects. Further screening of patients from the same population identified one additional affected carrier (1 of 692) with familial parkinsonism who shares the same haplotype. The mutation is located within the Roc domain of the protein and enhances GTP-binding and kinase activity, further implicating these activities as the mechanisms that underlie LRRK2-linked parkinsonism.

Original languageEnglish (US)
Pages (from-to)2156-2163
Number of pages8
JournalMovement Disorders
Volume25
Issue number13
DOIs
StatePublished - Oct 15 2010

Fingerprint

Parkinsonian Disorders
Parkinson Disease
Mutation
Levodopa
Age of Onset
GTP-Binding Proteins
Haplotypes
Phosphotransferases
Population

Keywords

  • Genetic
  • Kinase
  • LRRK2
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Aasly, J. O., Vilariño-Güell, C., Dachsel, J. C., Webber, P. J., West, A. B., Haugarvoll, K., ... Farrer, M. J. (2010). Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease. Movement Disorders, 25(13), 2156-2163. https://doi.org/10.1002/mds.23265

Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease. / Aasly, Jan O.; Vilariño-Güell, Carles; Dachsel, Justus C.; Webber, Philip J.; West, Andrew B.; Haugarvoll, Kristoffer; Johansen, Krisztina K.; Toft, Mathias; Nutt, John G.; Payami, Haydeh; Kachergus, Jennifer M.; Lincoln, Sarah J.; Felic, Amela; Wider, Christian; Soto-Ortolaza, Alexandra I.; Cobb, Stephanie A.; White, Linda R.; Ross, Owen A; Farrer, Matthew J.

In: Movement Disorders, Vol. 25, No. 13, 15.10.2010, p. 2156-2163.

Research output: Contribution to journalArticle

Aasly, JO, Vilariño-Güell, C, Dachsel, JC, Webber, PJ, West, AB, Haugarvoll, K, Johansen, KK, Toft, M, Nutt, JG, Payami, H, Kachergus, JM, Lincoln, SJ, Felic, A, Wider, C, Soto-Ortolaza, AI, Cobb, SA, White, LR, Ross, OA & Farrer, MJ 2010, 'Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease', Movement Disorders, vol. 25, no. 13, pp. 2156-2163. https://doi.org/10.1002/mds.23265
Aasly JO, Vilariño-Güell C, Dachsel JC, Webber PJ, West AB, Haugarvoll K et al. Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease. Movement Disorders. 2010 Oct 15;25(13):2156-2163. https://doi.org/10.1002/mds.23265
Aasly, Jan O. ; Vilariño-Güell, Carles ; Dachsel, Justus C. ; Webber, Philip J. ; West, Andrew B. ; Haugarvoll, Kristoffer ; Johansen, Krisztina K. ; Toft, Mathias ; Nutt, John G. ; Payami, Haydeh ; Kachergus, Jennifer M. ; Lincoln, Sarah J. ; Felic, Amela ; Wider, Christian ; Soto-Ortolaza, Alexandra I. ; Cobb, Stephanie A. ; White, Linda R. ; Ross, Owen A ; Farrer, Matthew J. / Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease. In: Movement Disorders. 2010 ; Vol. 25, No. 13. pp. 2156-2163.
@article{3678498e6b784f7ea58fb0d33c30b23b,
title = "Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease",
abstract = "Genealogical investigation of a large Norwegian family (F04) with autosomal dominant parkinsonism has identified 18 affected family members over four generations. Genetic studies have revealed a novel pathogenic LRRK2 mutation c.4309 A>C (p.Asn1437His) that co-segregates with disease manifestation (LOD = 3.15, Θ = 0). Affected carriers have an early age at onset (48 ± 7.7 SD years) and are clinically asymmetric and levodopa responsive. The variant was absent in 623 Norwegian control subjects. Further screening of patients from the same population identified one additional affected carrier (1 of 692) with familial parkinsonism who shares the same haplotype. The mutation is located within the Roc domain of the protein and enhances GTP-binding and kinase activity, further implicating these activities as the mechanisms that underlie LRRK2-linked parkinsonism.",
keywords = "Genetic, Kinase, LRRK2, Parkinson's disease",
author = "Aasly, {Jan O.} and Carles Vilari{\~n}o-G{\"u}ell and Dachsel, {Justus C.} and Webber, {Philip J.} and West, {Andrew B.} and Kristoffer Haugarvoll and Johansen, {Krisztina K.} and Mathias Toft and Nutt, {John G.} and Haydeh Payami and Kachergus, {Jennifer M.} and Lincoln, {Sarah J.} and Amela Felic and Christian Wider and Soto-Ortolaza, {Alexandra I.} and Cobb, {Stephanie A.} and White, {Linda R.} and Ross, {Owen A} and Farrer, {Matthew J.}",
year = "2010",
month = "10",
day = "15",
doi = "10.1002/mds.23265",
language = "English (US)",
volume = "25",
pages = "2156--2163",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "13",

}

TY - JOUR

T1 - Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease

AU - Aasly, Jan O.

AU - Vilariño-Güell, Carles

AU - Dachsel, Justus C.

AU - Webber, Philip J.

AU - West, Andrew B.

AU - Haugarvoll, Kristoffer

AU - Johansen, Krisztina K.

AU - Toft, Mathias

AU - Nutt, John G.

AU - Payami, Haydeh

AU - Kachergus, Jennifer M.

AU - Lincoln, Sarah J.

AU - Felic, Amela

AU - Wider, Christian

AU - Soto-Ortolaza, Alexandra I.

AU - Cobb, Stephanie A.

AU - White, Linda R.

AU - Ross, Owen A

AU - Farrer, Matthew J.

PY - 2010/10/15

Y1 - 2010/10/15

N2 - Genealogical investigation of a large Norwegian family (F04) with autosomal dominant parkinsonism has identified 18 affected family members over four generations. Genetic studies have revealed a novel pathogenic LRRK2 mutation c.4309 A>C (p.Asn1437His) that co-segregates with disease manifestation (LOD = 3.15, Θ = 0). Affected carriers have an early age at onset (48 ± 7.7 SD years) and are clinically asymmetric and levodopa responsive. The variant was absent in 623 Norwegian control subjects. Further screening of patients from the same population identified one additional affected carrier (1 of 692) with familial parkinsonism who shares the same haplotype. The mutation is located within the Roc domain of the protein and enhances GTP-binding and kinase activity, further implicating these activities as the mechanisms that underlie LRRK2-linked parkinsonism.

AB - Genealogical investigation of a large Norwegian family (F04) with autosomal dominant parkinsonism has identified 18 affected family members over four generations. Genetic studies have revealed a novel pathogenic LRRK2 mutation c.4309 A>C (p.Asn1437His) that co-segregates with disease manifestation (LOD = 3.15, Θ = 0). Affected carriers have an early age at onset (48 ± 7.7 SD years) and are clinically asymmetric and levodopa responsive. The variant was absent in 623 Norwegian control subjects. Further screening of patients from the same population identified one additional affected carrier (1 of 692) with familial parkinsonism who shares the same haplotype. The mutation is located within the Roc domain of the protein and enhances GTP-binding and kinase activity, further implicating these activities as the mechanisms that underlie LRRK2-linked parkinsonism.

KW - Genetic

KW - Kinase

KW - LRRK2

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=77954623892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954623892&partnerID=8YFLogxK

U2 - 10.1002/mds.23265

DO - 10.1002/mds.23265

M3 - Article

C2 - 20669305

AN - SCOPUS:77954623892

VL - 25

SP - 2156

EP - 2163

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 13

ER -